Search results
Wilcox CE, et al. , A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder. J Addict Med, 2018. 12(5): p. 339–345. [PMC free article] [Google Scholar] 38. Haass-Koffler CL, et al. , Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent ...
Available data support that oral penicillins, cefdinir, cefpodoxime, fluoroquinolones, azithromycin, tetracycline, nitrofurantoin, secnidazole, tinidazole, and fluconazole can be safely used with concomitant alcohol consumption. Data are equivocal for trimethoprim-sulfamethoxazole.
5 gru 2020 · Pharmacological and behavioural treatments for alcohol use disorders (AUDs) are effective but the uptake is limited. Primary care could be a key setting for identification and continuous care for AUD due to accessibility, low cost and acceptability to patients.
20 maj 2020 · The FDA has approved three medications for alcohol use disorder: naltrexone, acamprosate, and disulfiram. Additionally, other medications including gabapentin, baclofen, topiramate, and ondansetron show promise off-label for treating alcohol use disorder.
13 lis 2019 · This systematic review and meta-analysis aims to guide improvement of design and implementation of evidence-based models of care for the treatment of alcohol use disorder in primary health care settings.
3 wrz 2024 · Pharmacologic treatment of alcohol use disorder has focused on altering the reinforcing effects of alcohol use. Medication development has focused on several neurotransmitter systems that mediate reinforcement including opioid, glutamate, gamma-aminobutyric acid, and serotonin systems.
5 sty 2015 · 1. Introduction. Substance-related and addictive disorders are chronic conditions estimated to occur in one in five patients in primary care [1, 2]. Primary care is an important entry point for all patients suffering from chronic conditions.
